0001415889-18-001204.txt : 20180801 0001415889-18-001204.hdr.sgml : 20180801 20180801160535 ACCESSION NUMBER: 0001415889-18-001204 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180730 FILED AS OF DATE: 20180801 DATE AS OF CHANGE: 20180801 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: AHMED NADIM CENTRAL INDEX KEY: 0001731193 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34912 FILM NUMBER: 18984753 MAIL ADDRESS: STREET 1: C/O CELGENE CORPORATION STREET 2: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CELGENE CORP /DE/ CENTRAL INDEX KEY: 0000816284 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222711928 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 BUSINESS PHONE: (908)673-9000 MAIL ADDRESS: STREET 1: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 4 1 form4-08012018_040820.xml X0306 4 2018-07-30 0000816284 CELGENE CORP /DE/ CELG 0001731193 AHMED NADIM C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT NJ 07901 false true false false PRES., HEMATOLOGY AND ONCOLOGY Stock Option (right to buy) 88.91 2018-07-30 4 A 0 10548 0 A 2028-07-30 Common Stock 10548 10548 D Option is immediately exercisable and will vest in four equal annual installments commencing on July 30, 2019. The option was issued pursuant to the Company's 2017 Stock Incentive Plan. /s/ Mark J. Alles, Attorney-in-Fact 2018-08-01